Bausch, Salix's Trimmed IBS Drug IP Suit Moves to W.Va.
A New Jersey federal judge on Tuesday dismissed several Mylan entities from a patent suit relating to their purported plans to market generic versions of gastrointestinal drug Trulance, while also tossing...To view the full article, register now.
Already a subscriber? Click here to view full article